Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

L1P-1F (TRIOS 5)

K-Number: K221249 · 2022-09-16

Decision Date2022-09-16
Product CodeNBL
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

L1P-1F (TRIOS 5) is a medical device manufactured by 3Shape TRIOS A/S. It received FDA 510(k) clearance on 2022-09-16 under approval number K221249. The device is classified under product code NBL. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the L1P-1F (TRIOS 5)?

L1P-1F (TRIOS 5) is a medical device that received FDA 510(k) clearance on 2022-09-16. It is manufactured by 3Shape TRIOS A/S. The 510(k) number is K221249.

When was L1P-1F (TRIOS 5) approved by the FDA?

L1P-1F (TRIOS 5) received FDA 510(k) clearance on 2022-09-16, under approval number K221249.

What company makes L1P-1F (TRIOS 5)?

L1P-1F (TRIOS 5) is manufactured by 3Shape TRIOS A/S.

What is the FDA product code for L1P-1F (TRIOS 5)?

The FDA product code for L1P-1F (TRIOS 5) is NBL.

Other Devices by 3Shape TRIOS A/S

Related Devices (Code: NBL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.